| Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732) |
|---|
| 06/06/2001 | CN1066715C Bleaching compounds comprising substituted benzoyl caprolactam bleach activators |
| 06/05/2001 | US6242645 Biological activity enhancer, deoxofluorination agent of interest in medicinal and agrochemical products |
| 05/31/2001 | WO1999064041A9 Multibinding agents that modulate nmda receptors |
| 05/30/2001 | EP1102752A1 Succinoylamino lactams as inhibitors of a beta protein production |
| 05/30/2001 | EP1102743A1 Amide derivatives which are useful as cytokine inhibitors |
| 05/30/2001 | EP1102720A1 Method for distilling ammonia |
| 05/30/2001 | EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors |
| 05/30/2001 | EP0842153B1 Method of preparing norbenzomorphane as an intermediate in the preparation of pharmaceutically useful benzomorphane derivatives, in particular (-)-(1r,5s,2"r)-3'-hydroxy-2-(2-methoxypropyl)-5,9,9-trimethyl-6,7-benzomorphane |
| 05/30/2001 | EP0794184B1 6-methoxy-1h-benzotriazole-5-carboxamide derivatives, process for producing the same, and medicinal composition containing the same |
| 05/30/2001 | EP0641320B1 Substituted (s)-3-phenylpiperidine derivatives, their preparation and their use as dopamine autoreceptor antagonists |
| 05/30/2001 | CN1297433A Processes for producing epsilon-caprolactams |
| 05/29/2001 | US6239148 Treatment of painful, hyperalgesic and/or inflammatory conditions in which c-fibers play a role by eliciting neurogenic pain, insulin resistance in diabetes mellitus or aging, inhibit insulin antagonizing peptide, |
| 05/29/2001 | US6239127 Certain substituted caprolactams, pharmaceutical compositions containing them and a process for their preparation |
| 05/25/2001 | WO2001035964A1 Substituted 1-benzazepines and derivatives thereof |
| 05/25/2001 | CA2391498A1 Substituted 1-benzazepines and derivatives thereof |
| 05/23/2001 | EP1101757A1 Heterocyclic compounds as tachykinin receptor antagonists |
| 05/23/2001 | EP1101735A1 Method for the removal of the templating agent from synthetic zeolites |
| 05/23/2001 | EP1100519A1 Multibinding agents that modulate nmda receptors |
| 05/17/2001 | WO2001034571A1 β-AMINOACID COMPOUNDS USEFUL FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS |
| 05/17/2001 | CA2390376A1 .beta.-aminoacid compounds useful for inhibiting .beta.-amyloid peptide release and/or its synthesis |
| 05/16/2001 | EP1098897A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 05/16/2001 | EP1098875A1 Method for cyclizing hydrolysis of an aminonitrile compound into lactam |
| 05/16/2001 | EP1098705A1 Method for reactivating a catalyst for cyclizing hydrolysis of an aminonitrile into a lactam and use of the regenerated catalyst for making lactams |
| 05/16/2001 | CN1295561A N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres |
| 05/16/2001 | CN1295479A Beta 2-adrenergic receptor agonist |
| 05/15/2001 | US6232118 Nucleic acid encoding a protein of defined amino acid sequence; recombinant cell culture production; diagnosis; probes; treatment of parkinson's disease and other nervous system disorders with reduced side effects; gene therapy |
| 05/15/2001 | CA2238978C Retroviral protease inhibiting compounds |
| 05/09/2001 | EP1097920A1 Intermediate for condensed benzazepine derivatives |
| 05/09/2001 | EP1097719A1 NEP inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097718A1 NPY antagonists for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097707A1 Treatment of female sexual dysfunction |
| 05/09/2001 | EP1097706A1 Phosphodiesterase inhibitors for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2324484A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323464A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323191A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323183A1 Compounds for the treatment of female sexual dysfunction |
| 05/02/2001 | EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 05/02/2001 | CN1293669A Benzylpiperazingl-and benzylipeeridinyl ethanone derivatives, their preparation method and their use as dopamine D receptor antagonists |
| 05/01/2001 | US6225465 Process for the aminocarbonylation of benzazepines and benzodiazepines |
| 05/01/2001 | US6225307 Caprolactam-phenyl phenylcarbamate |
| 05/01/2001 | CA2197178C Bicyclolactam compounds, use of the same and intermediate in the production of the same |
| 04/26/2001 | WO2001029005A1 Bicyclic vasopressin agonists |
| 04/26/2001 | CA2387886A1 Bicyclic vasopressin agonists |
| 04/25/2001 | EP1093372A1 CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS |
| 04/19/2001 | DE19947297A1 Cyclische Biphenyle, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel Cyclic biphenyls, processes for their preparation and their use as medicaments |
| 04/17/2001 | US6218535 Caprolactam production process |
| 04/17/2001 | US6218385 1,2,4,5-Tetrahydro-benzo[D]azepin derivatives |
| 04/12/2001 | WO2001025212A2 Cyclic biphenyls, method for the production thereof, and their use as medicaments |
| 04/11/2001 | EP1089989A1 Inhibitors of alpha4beta1 mediated cell adhesion |
| 04/11/2001 | EP1089981A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis. |
| 04/11/2001 | EP1089980A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| 04/11/2001 | EP1089977A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| 04/11/2001 | EP1089972A1 Method for evaporating aminonitrile |
| 04/11/2001 | CN1291183A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 04/11/2001 | CN1064354C Trilcyclic benzazepine vasopressin antagnonists |
| 04/11/2001 | CN1064353C Method for simultaneously preparing caprolactam and hexamethylene diamine |
| 04/10/2001 | US6214858 Caspases and apoptosis |
| 04/10/2001 | US6214829 Piperazine compounds, their preparation, and methods of using them |
| 04/10/2001 | US6214822 Substituted aza and diazacycloheptane and cyclooctane compounds and their use |
| 04/05/2001 | WO2001023497A1 Organic electroluminescent element |
| 04/05/2001 | WO2001023357A2 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 04/04/2001 | CN1064042C Intermediate of benzazepine derivative |
| 04/03/2001 | US6211174 Osteoporosis; milk production and carcass quality in livestock; short stature; metabolic disorders |
| 04/03/2001 | US6211173 Use of 2,3,4,5-tetrahydro-1H-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders |
| 03/29/2001 | WO2001021305A1 Layered silicate catalysts pillared with metal oxide |
| 03/28/2001 | EP1086078A1 Neuropeptide y5 receptor antagonists |
| 03/28/2001 | EP1085894A1 Beta 3-adrenergic receptor agonists |
| 03/28/2001 | EP1085889A2 Novel therapeutic agents that modulate endothelin receptors |
| 03/28/2001 | EP1085887A2 Novel angiotensin receptor modulators and their uses |
| 03/28/2001 | EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 03/28/2001 | EP1085868A1 H1-histamine receptor antagonists |
| 03/28/2001 | EP1085847A2 Novel therapeutic agents that modulate estrogen receptors |
| 03/27/2001 | US6207860 Fluorinating agents, far less potential of violent decomposition and attendant high gaseous by-product evolvement, useful for deoxofluorination of alcohols and ketones, |
| 03/27/2001 | US6207824 Using macroporous cation exchange resin |
| 03/27/2001 | US6207708 For therapy and prophylaxis of autoimmune and/or inflammatory conditions affecting the joints such as arthritis, and inflammatory bowel disease, cardivascular ischemia, diabetes, congestive heart failure, myocarditis, atherosclerosis, |
| 03/22/2001 | WO2001019797A2 HYDROXYALKANOYL AMINOLACTAMS AND RELATED STRUCTURES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 03/22/2001 | WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors |
| 03/22/2001 | CA2377221A1 Hydroxyalkanoyl aminolactams and related structures as inhibitors of a.beta. protein production |
| 03/21/2001 | EP1084107A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
| 03/21/2001 | EP1084106A1 N-linked sulfonamides of heterocyclic carboxylic acids or carboxylic acid isosteres |
| 03/21/2001 | EP1083921A1 Novel leukotriene receptor antagonists and their uses |
| 03/21/2001 | EP1083917A1 Novel analgesic agents |
| 03/21/2001 | EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors |
| 03/21/2001 | EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS |
| 03/15/2001 | WO2001017971A1 Process for the preparation of 2,3-dihydroazepine derivatives |
| 03/15/2001 | WO2001017947A1 Process for the preparation of 2,3-dihydroazepine compounds |
| 03/15/2001 | CA2384145A1 Process for the preparation of 2,3-dihydroazepine compounds |
| 03/14/2001 | EP1083166A1 Novel substituted guanidine derivatives and process for producing the same |
| 03/14/2001 | EP1082306A1 Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |
| 03/14/2001 | EP1082301A1 Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres |
| 03/14/2001 | EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors |
| 03/13/2001 | US6201120 Synthesis of 11-aryl-5,6-dihydro-11H-dibenz[b,e]azepines |
| 03/08/2001 | WO2001016110A1 Bleach boosting components, compositions and laundry methods |
| 03/08/2001 | WO1999063930A8 Novel angiotensin receptor modulators and their uses |
| 03/08/2001 | CA2381892A1 Bleach boosting components, compositions and laundry methods |
| 03/07/2001 | EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors |
| 03/06/2001 | US6197737 Bleaching compounds comprising substituted benzoyl caprolactam bleach activators |
| 03/01/2001 | WO2001014328A2 Substituted ureas as cell adhesion inhibitors |
| 02/28/2001 | EP1077941A1 Compounds with growth hormone releasing properties |
| 02/28/2001 | EP1077931A1 Benzamide derivatives for the treatment of diseases mediated by cytokines |